R. De Crevoisier - HES SO Valais Publications - Aigaion 2.0

BROWSE
EXPORT
- Export all publications
- Export author
SORT BY
- Author
- Title
- Type/Journal
- Year
- Recently added
SITE
- Help
- About this site
GUEST USER
anonymous
Topic Subscribe
LOGIN
Name:

Password:

Deutsch, English, Nederlands, Norsk, Português, <more...>

First name(s):	R.
von-part:	De
Last name(s):	Crevoisier

Joel Castelli, Adrien Depeursinge, Vanessa Ndoh, John O. Prior, Esat Ozsahin, Anne Devillers, Hanan Bouchaab, Enrique Chajon, R. De Crevoisier, Nathaniel Scher, Franck Jegoux, B. Laguerre, B. De Bari and J. Bourhis, A PET-based nomogram for oropharyngeal cancers (2017), in: European Journal of Cancer, 75(222-230)

[]: IF 2015 = 6.16

attachment

Pierre Fontaine, Vincent Andrearczyk, Valentin Oreiller, Daniel Abler, Joel Castelli, Oscar Acosta, R. De Crevoisier, Martin Vallières, Mario Jreige, John O. Prior and Adrien Depeursinge, Cleaning Radiotherapy Contours for Radiomics Studies, is it Worth it? A Head and Neck Cancer Study (2022), in: Clinical and Translational Radiation Oncology, 33(153-158)

[]: IF 2021 = 4.739

attachment

Adrien Depeursinge, Yashin Dicente Cid, Roger Schaer, R. De Crevoisier, John O. Prior and Joel Castelli, Comparing 18-FDG PET 3D texture attributes for the prediction of survival and recurrence in oropharyngeal cancers treated with radiotherapy, in: Workshop on the Prediction and Modeling of response to Molecular and External Beam Radiotherapies, Le Bono, France, 2017

attachment

Pierre Fontaine, François-Georges Riet, Joel Castelli, Antoine Simon, Adrien Depeursinge, R. De Crevoisier and Oscar Acosta, Comparison of feature selection in radiomics for the prediction of overall survival after radiotherapy for hepatocellular carcinoma, in: IEEE Engineering in Medicine and Biology Conference, 2020

attachment

Gwenaelle Creff, Franck Jegoux, Xavier Palard, Adrien Depeursinge, Ronan Abgral, Remi Marianowski, Thomas Eugene, Olivier Malard, R. De Crevoisier, Anne Devillers and Joel Castelli, FDG-PET/CT-based prognostic survival model after surgery for head and neck cancer (2022), in: Journal of Nuclear Medicine, 63:1

[]: IF 2020 = 10.057

attachment

Pierre Fontaine, Oscar Acosta, François-Georges Riet, Joel Castelli, Khemara Gnep, Antoine Simon, Adrien Depeursinge and R. De Crevoisier, How to find the best radiomics features for prediction of overall survival in SBRT for hepatocellular carcinoma?, in: European SocieTy for Radiotherapy & Oncology, 2019

attachment

Joel Castelli, Adrien Depeursinge, B. De Bari, Anne Devillers, R. De Crevoisier, J. Bourhis and John O. Prior, Metabolic Tumor Volume and Total Lesion Glycolysis in Oropharyngeal Cancer treated with definitive radiotherapy: Which threshold is the best predictor of local control ? (2017), in: Clinical Nuclear Medicine, 42:6(e281–e285)

[]: IF 2015 = 4.27

attachment

Joel Castelli, B. De Bari, Adrien Depeursinge, A. Simon, A. Devilliers, G. Roman Jimenez, John O. Prior, R. De Crevoisier and J. Bourhis, Overview of the predictive value of quantitative 18 FDG PET in head and neck cancer treated with chemoradiotherapy (2016), in: Critical Reviews in Oncology/Hematology, 108(40-51)

[]: IF 2015 = 5.039

attachment

Joel Castelli, Adrien Depeursinge, Anne Devillers, B. Campillo-Gimenez, Yashin Dicente Cid, John O. Prior, Enrique Chajon, Franck Jegoux, C. Sire, Oscar Acosta, X. Sun, B. De Bari, J. Bourhis and R. De Crevoisier, PET-based predictive survival model after radiotherapy for head and neck cancer (2019), in: European Journal of Nuclear Medicine and Molecular Imaging, 46:3(638-649)

[]: IF 2016 = 7.277

attachment

[URL]

Pierre Fontaine, Oscar Acosta, Joel Castelli, R. De Crevoisier, Henning Müller and Adrien Depeursinge, The Importance of Feature Aggregation in Radiomics: A Head and Neck Cancer Study (2020), in: Nature Scientific Reports, 10:19679

[]: IF 2019 = 3.998

attachment

Joel Castelli, Adrien Depeursinge, Vanessa Ndoh, Anne Devillers, Yashin Dicente Cid, Roger Schaer, John O. Prior, J. Bourhis, C. Cire and R. De Crevoisier, Valeur de la TEP au 18-FDG pour prédire la récidive dans les cancers ORL non oropharyngé traités par radio-chimiothérapie, in: Société Française de radiothérapie Oncologique, 2017

attachment

processing time: 0.6258 seconds.